Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $8.99 million
- Book Value:
- Revenue TTM:
- $62.05 million
- Operating Margin TTM:
- Gross Profit TTM:
- $23.21 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
ConforMIS Inc had its IPO on 2015-07-01 under the ticker symbol CFMS.
The company operates in the Healthcare sector and Medical Devices industry. ConforMIS Inc has a staff strength of 295 employees.
Shares of ConforMIS Inc opened at $1.19 at the start of the last trading session i.e. 2023-03-24.
The stocks traded within a range of $1.18 - $1.22, and closed at $1.2.
This is a -2.44% slip from the previous day's closing price.
A total volume of 29,887 shares were traded at the close of the day’s session.
In the last one week, shares of ConforMIS Inc have slipped by -10.45%.
ConforMIS Inc's Key Ratios
ConforMIS Inc has a market cap of $8.99 million, indicating a price to book ratio of 0.3687 and a price to sales ratio of 0.388.
In the last 12-months ConforMIS Inc’s revenue was $62.05 million with a gross profit of $23.21 million and an EBITDA of $-42246000. The EBITDA ratio measures ConforMIS Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, ConforMIS Inc’s operating margin was -74.58% while its return on assets stood at -24.17% with a return of equity of -65.24%.
In Q4, ConforMIS Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 12.9%.
ConforMIS Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-6.42 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0.21. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into ConforMIS Inc’s profitability.
ConforMIS Inc stock is trading at a EV to sales ratio of 0.1309 and a EV to EBITDA ratio of 0.166. Its price to sales ratio in the trailing 12-months stood at 0.388.
ConforMIS Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $94.05 million
- Total Liabilities
- $14.07 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
ConforMIS Inc ended 2023 with $94.05 million in total assets and $0 in total liabilities. Its intangible assets were valued at $94.05 million while shareholder equity stood at $54.18 million.
ConforMIS Inc ended 2023 with $0 in deferred long-term liabilities, $14.07 million in other current liabilities, in common stock, $-581324000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $48.67 million and cash and short-term investments were $48.67 million. The company’s total short-term debt was $1,932,000 while long-term debt stood at $20.56 million.
ConforMIS Inc’s total current assets stands at $79.27 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $9.77 million compared to accounts payable of $4.16 million and inventory worth $18.91 million.
In 2023, ConforMIS Inc's operating cash flow was $0 while its capital expenditure stood at $321000.
Comparatively, ConforMIS Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
ConforMIS Inc stock is currently trading at $1.2 per share. It touched a 52-week high of $18.72 and a 52-week low of $18.72. Analysts tracking the stock have a 12-month average target price of $28.
Its 50-day moving average was $2.07 and 200-day moving average was $4.52 The short ratio stood at 1.89 indicating a short percent outstanding of 0%.
Around 370.4% of the company’s stock are held by insiders while 4027.6% are held by institutions.
Frequently Asked Questions About ConforMIS Inc
Similar Industry Stocks (Medical Devices)
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.